Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.660
+0.170 (11.41%)
At close: Jul 27, 2026, 4:00 PM EDT
1.630
-0.030 (-1.81%)
After-hours: Jul 27, 2026, 7:55 PM EDT
Neumora Therapeutics Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Neumora Therapeutics stock has a consensus rating of "Buy" and an average price target of $6.28. The average 1-year stock price forecast is 278.31% higher than the current stock price, while the lowest is $3.00 (+80.72%) and the highest is $14 (+743.37%).
Price Target: $6.28 (+278.31%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Neumora Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Maintains $5 | Buy | Maintains | $5 | +201.20% | Jul 27, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 27, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +201.20% | Jul 13, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $4 | Buy | Maintains | $4 | +140.96% | Jun 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $18 → $7 | Buy | Reiterates | $18 → $7 | +321.69% | Jun 16, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
1.34M
EPS This Year
-0.92
from -1.45
EPS Next Year
-0.74
from -0.92
EPS and Forward PE are based on non-GAAP adjusted numbers.